INTC Intel Corporation

Intel Promotes Three Corporate Officers

Intel Corporation today announced that its board of directors has promoted three corporate officers.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170530005260/en/

Sandra Rivera, senior vice president and general manager of the Network Platforms Group at Intel Cor ...

Sandra Rivera, senior vice president and general manager of the Network Platforms Group at Intel Corporation (Credit: Intel Corporation)

“Each of these proven Intel leaders has taken on expanded roles overseeing important areas of the business,” said Intel CEO Brian Krzanich. “These promotions recognize the scope and significance of the organizations they lead at Intel.”

Navin Shenoy was promoted from senior vice president to executive vice president. Shenoy is the newly appointed general manager of Intel’s Data Center Group (DCG), an important growth business that spans servers, network and storage solutions that are driving the adoption of pervasive cloud computing, virtualization of network infrastructure and artificial intelligence. Shenoy is responsible for the P&L, strategy and product development spanning server, storage and network solutions for cloud service providers, communications service providers, enterprise and government infrastructure customers. He joined Intel in 1995 and is based in Santa Clara, California.

Gregory Bryant was promoted from corporate vice president to senior vice president. He is the general manager of the Client Computing Group (CCG), Intel’s largest and most profitable business, which encompasses PCs, home gateways and other compute devices. Bryant recently succeeded Shenoy in this role and is responsible for the P&L, strategy and product development. He joined Intel in 1992 and is based in Hillsboro, Oregon.

Sandra Rivera was promoted from corporate vice president to senior vice president. She is general manager of the Network Platforms Group, which is the data center business group charged with providing innovative network technology and products to the market. In this role, Rivera manages the P&L, strategy and product development for solutions and services providers worldwide. She is also the executive sponsor guiding Intel's strategy, commitments and deliverables for 5G. Rivera joined Intel in 2000 and will be based in Santa Clara, California.

With these promotions, Bryant and Rivera join Shenoy on Intel’s management committee.

About Intel

Intel (NASDAQ: INTC) expands the boundaries of technology to make the most amazing experiences possible. Information about Intel can be found at newsroom.intel.com and intel.com.

Intel and the Intel logo are trademarks of Intel Corporation in the United States and other countries.

*Other names and brands may be claimed as the property of others.

EN
30/05/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Intel Corporation

Moody's Ratings says Intel's acquisition of Apollo's minority interest...

Announcement: Moody's Ratings says Intel's acquisition of Apollo's minority interest in Ireland JV is credit positive. Global Credit Research- 01 Apr 2026. New York, April 01, 2026-- Moody's Ratings said that Intel Corporation's plan to repurchase the 49% equity interest in its joint venture with Apollo, which owns and operates Fab 34 in Ireland, is credit positive for Intel.

Antoine Chkaiban
  • Antoine Chkaiban

Intel: is 35-40% Foundry gross margin ever achievable?

The gross margin of Intel Foundry is in negative territory today and were guided, back in 2024, to reach 35-40% in 2030. In today’s research we gather all what we know and can estimate about Intel and TSMC’s cost structures at the leading edge. From this baseline, we analyze the drivers of the current gap between the two, and assess how Intel could eventually achieve its goal. ​​​​Is improving scale and process efficiency enough to get to 40% gross margins, despite the structurally higher cost...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NKTR NEKTAR THERAPEUTICS
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
ACRS ACLARIS THERAPEUTICS INC.
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ORIC KEROS THERAPEUTICS
ZNTL ORIC PHARMACEUTICALS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
SANA VIRIDIAN THERAPEUTICS INC
PLTK SANA BIOTECHNOLOGY
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
PEPG TYRA BIOSCIENCES INC
EWTX PEPGEN INC
SLDB EDGEWISE THERAPEUTICS INC
DDI SOLID BIOSCIENCES INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B APOGEE THERAPEUTICS INC
DNTH EMBRACER GROUP AB
ORKA DIANTHUS THERAPEUTICS INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
IMA JADE BIOSCIENCES INC
IMAGENEBIO INC.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch